New era for ME/CFS research as top cytokine study attracts media headlines
The immune systems of patients who have recently developed ME/CFS look markedly different from those who have been ill for much longer, according to a major new study from Drs. Ian Lipkin and Mady Hornig at Columbia University. This shift in immune function hadn’t been seen before.
Discuss the article on the Forums.

Salicinium Trial for Viruses...as it relates to Nagalase and GC-Maf

Discussion in 'Active Clinical Studies' started by Zensational, Jul 13, 2012.

  1. Zensational

    Zensational Senior Member

    Messages:
    104
    Likes:
    55
    Orlando, Florida
    I will keep you posted of my progress.
     
  2. Sushi

    Sushi Moderator and Senior Member Albuquerque

    Messages:
    8,348
    Likes:
    8,781
    Albuquerque
    This sounds very interesting! I wish you the very best on this trial.

    Keep up posted.

    Best,
    Sushi
     
  3. I look forward to seeing what you post. When I searched for Salicinium one of the best finds was at http://www.slideshare.net/chadpriddle/salicinium-12260170 which clarifies the action.

    If you or anyone finds more helpful information about
    1) Measuring Nagalase levels
    2) Getting and using GcMAF
    3) Getting or making and using MAF 314
    4) Getting or making and using MAF 878
    5) Getting and using Salicinium
    6) Other non-patented effective treatments for ME/CFS or cancer
    THEN please feel free to send me a document or a link about it.

    My hope is to build a detailed tree of questions, answers, and arguments for and against those answers that will be easy to explore and extend. The form of the tree is derived from the nearly ancient IBIS, Issue Based Information System. An expensive but helpful book about the approach is called Dialogue Mapping, by Jeff Conklin. I think it should be on a wiki and freely available for both reading and extending. Wanna help with that effort??

    Richard AKA Dick@CFCL.com
     

See more popular forum discussions.

Share This Page